BD to Present at Wells Fargo 2025 Healthcare Conference
BD (NYSE:BDX), a leading global medical technology company, has announced its participation in the upcoming Wells Fargo 2025 Healthcare Conference.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
BD (NYSE:BDX), a leading global medical technology company, has announced its participation in the upcoming Wells Fargo 2025 Healthcare Conference. The company's presentation is scheduled for Wednesday, September 3, 2025, at 8:00 a.m. Eastern Time.
Investors and interested parties can access the live webcast of the presentation through BD's investor relations website at investors.bd.com. A replay will be made available on the same platform after the event concludes.
Details
News Market Reaction – BDX
On Aug 15, the first trading day after this news, BDX closed 0.48% above the previous close.
Data tracked by StockTitan Argus for the Aug 15 session.
AI-generated analysis. How Rhea-AI works. Not financial advice.
The live webcast of BD's presentation can be accessed from the BD investor relations website, investors.bd.com. A replay of the event will be available on the same webpage following its conclusion.
About BD
BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its more than 70,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD, please visit bd.com or connect with us on LinkedIn at www.linkedin.com/company/bd1/, X (formerly Twitter) @BDandCo or Instagram @becton_dickinson.
Contacts: | |
Media: | Investors: |
Troy Kirkpatrick | Adam Reiffe |
VP, Public Relations | Sr. Director, Investor Relations |
858.617.2361 | 201.847.6927 |
View original content:https://www.prnewswire.com/news-releases/bd-to-present-at-wells-fargo-2025-healthcare-conference-302529820.html
SOURCE BD (Becton, Dickinson and Company)
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.